Literature DB >> 20560070

Construction of unmarked deletion mutants in mycobacteria.

Houhui Song1, Frank Wolschendorf, Michael Niederweis.   

Abstract

Site-specific recombinases such as the Saccharomyces cerevisiae Flp and the P1 phage Cre proteins have been increasingly used for the construction of unmarked deletions in bacteria. Both systems consist of an antibiotic resistance gene flanked by recognition sites in direct orientation and a curable plasmid for temporary expression of the respective recombinase gene. In this chapter, we describe strategies and methods of how to use sequence-specific recombination mediated by Flp and Cre to construct mutants of Mycobacterium smegmatis, Mycobacterium bovis BCG, and Mycobacterium tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20560070     DOI: 10.1007/978-1-59745-207-6_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Two systems for targeted gene deletion in Coxiella burnetii.

Authors:  Paul A Beare; Charles L Larson; Stacey D Gilk; Robert A Heinzen
Journal:  Appl Environ Microbiol       Date:  2012-04-20       Impact factor: 4.792

2.  New Insights Into the Function of Flavohemoglobin in Mycobacterium tuberculosis: Role as a NADPH-Dependent Disulfide Reductase and D-Lactate-Dependent Mycothione Reductase.

Authors:  Naveen Thakur; Amar Nath Sharma; Mangesh Dattu Hade; Ajay Chhaya; Ashwani Kumar; Ravinder Singh Jolly; Kanak L Dikshit
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

3.  Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis.

Authors:  Paras Jain; Tsungda Hsu; Masayoshi Arai; Karolin Biermann; David S Thaler; Andrew Nguyen; Pablo A González; Joann M Tufariello; Jordan Kriakov; Bing Chen; Michelle H Larsen; William R Jacobs
Journal:  MBio       Date:  2014-06-03       Impact factor: 7.867

Review 4.  Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis.

Authors:  Reginaldo G Bastos; Heba F Alzan; Vignesh A Rathinasamy; Brian M Cooke; Odir A Dellagostin; Raúl G Barletta; Carlos E Suarez
Journal:  Vaccines (Basel)       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.